DC
EW icon

Diametric Capital’s Edwards Lifesciences EW Stock Holding History

Diametric Capital’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4,811
Closed -$460K – 405
2024
Q1 		$460K Sell
4,811
-463
-9% -$38.9K 0.26% 90
2023
Q4 		$402K Buy
+5,274
New +$367K 0.24% 136
2023
Q3 		– Sell
-3,609
Closed -$340K – 374
2023
Q2 		$340K Sell
3,609
-6,678
-65% -$580K 0.15% 178
2023
Q1 		$851K Buy
+10,287
New +$809K 0.41% 69
2022
Q3 		– Sell
-9,437
Closed -$897K – 280
2022
Q2 		$897K Buy
+9,437
New +$977K 0.66% 32
2019
Q2 		– Sell
-33,117
Closed -$2.11M – 135
2019
Q1 		$2.11M Buy
+33,117
New +$1.89M 1.66% 15
2018
Q4 		– Sell
-22,017
Closed -$1.28M – 109
2018
Q3 		$1.28M Buy
+22,017
New +$1.08M 1.11% 36

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Diametric Capital's EW Position: Q2 2024 in Review

Diametric Capital sold out of Edwards Lifesciences (EW) in Q2 2024, closing a stake of 4,811 shares — an estimated $460K sold.

Diametric Capital first reported a position in EW in Q3 2018 and held it in 7 quarters. The position peaked at $2.11M in Q1 2019. 1,296 funds tracked by Wall St. Rank hold EW as of Q2 2024.

  • Diametric Capital reported no remaining Edwards Lifesciences position as of Q2 2024 after selling out during the quarter.
  • Diametric Capital sold 4,811 Edwards Lifesciences shares in Q2 2024, an estimated $460K.
  • Diametric Capital first reported a position in Edwards Lifesciences in Q3 2018 and held it in 7 quarters.
  • Diametric Capital's Edwards Lifesciences position peaked at $2.11M in Q1 2019.
  • 1,296 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2024.

Based on Diametric Capital's 13F filing for Q2 2024, filed 13 Aug 2024.